Published in Anesteziol Reanimatol on October 26, 1992
Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndrome analysis. J Urol (1998) 0.90
[Prostaglandins E in the primary tumor, metastases, and ascitic fluid of patients with ovarian cancer]. Biull Eksp Biol Med (1997) 0.83
CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients. Adv Exp Med Biol (1999) 0.81
[Sex steroid hormones and their receptors in pancreatic neoplasms]. Biull Eksp Biol Med (1998) 0.81
[Qualitative and quantitative characteristics of estrogen receptors in patients with atrophic gastritis and stomach cancer]. Ukr Biokhim Zh (1999) (2000) 0.80
[The specificity of expression of molecular biological markers in tumors of the mammary gland]. Vestn Ross Akad Med Nauk (2004) 0.80
[Antioxidant defense of in vivo selected high- and low-malignant variants of tumor cells in the Syrian hamster]. Dokl Akad Nauk (1996) 0.79
[Tumor-induced immunosuppression in breast cancer patients]. Eksp Onkol (1990) 0.79
[Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells by platinum drugs]. Antibiot Khimioter (2003) 0.79
[The biochemical markers of bone remodeling in cancer patients with skeletal involvement]. Vopr Onkol (2000) 0.79
Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib. Biochemistry (Mosc) (2008) 0.79
Studies of some mechanisms of drug resistance in chronic myeloid leukemia (CML). Adv Exp Med Biol (1999) 0.78
[Vascular endothelial growth factor and insulin-like-growth factors in prostate cancer. ]. Urologiia (2004) 0.78
[The diagnosis and correction of hemostatic system disorders during surgical coagulopathic hemorrhages in cancer patients]. Anesteziol Reanimatol (1996) 0.78
[Immunohistochemical demonstration of the localization of melatonin and N-acetylserotonin in enterochromaffin cells]. Biull Eksp Biol Med (1976) 0.78
Influence of exogenous RAR alpha gene on MDR1 expression and P-glycoprotein function in human and rodent cell lines. Br J Cancer (1998) 0.78
[Steroid hormone receptors in osteogenic sarcomas]. Vopr Onkol (1989) 0.77
[Testosterone stimulation of the growth of a human osteogenic sarcoma strain transplanted into athymic rats]. Eksp Onkol (1988) 0.77
[Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis]. Ter Arkh (2005) 0.77
[Cytoplasmatic androgen receptors in malignant bone neoplasms and their relation to the morphological characteristics of the tumor]. Arkh Patol (1987) 0.77
[Androgen receptors in the cytosol fraction of a spontaneous osteogenic sarcoma in dogs]. Vopr Onkol (1992) 0.77
[Cytoplasmic receptors of steroid sex hormones in malignant tumors amd precancerous processes of the human oral mucosa]. Vopr Onkol (1987) 0.77
[Antioxidant defense status of children in the early post-operative period in Wilms' tumor] . Vopr Onkol (2000) 0.77
[Sugammadex use experience in pediatric oncology]. Anesteziol Reanimatol (2013) 0.77
[EFR-like peptides and their receptors as prognostic factors for the survival of patients with non-small-cell lung cancer]. Vopr Onkol (1999) 0.77
[Effect of the spread of the process and treatment on the phenotype of peripheral blood lymphocytes in patients with prostatic cancer]. Urol Nefrol (Mosk) (1996) 0.77
[Immunohistochemical study of E-cadherin, beta-catenin and CD-44v6 expression in the cells of primary colon cancer and its metastases]. Arkh Patol (2006) 0.77
[Prostaglandins E in malignant stomach neoplasms]. Vopr Onkol (1994) 0.76
A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer. Dokl Biochem Biophys (2007) 0.76
[Regulatory T-cells and their role in antitumor immune response]. Vopr Onkol (2009) 0.76
Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapy. Bull Exp Biol Med (2006) 0.76
[The pharmacological and hormonal effects of carbamazepine and valproic acid in the treatment of reproductive age women with epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.76
[Tissue inhibitor of metalloproteinase-1 (TIMP-1) in colorectal cancer: correlation with clinico-morphological factors]. Vopr Onkol (2009) 0.76
Intracellular localization and content of YB-1 protein in multidrug resistant tumor cells. Biochemistry (Mosc) (2006) 0.76
[Expression of nm23 and c-erbB-2 proteins in cells of primary colorectal cancer and its metastases]. Arkh Patol (2003) 0.75
[Midazolam in children. Alternative routes of administration]. Anesteziol Reanimatol (2007) 0.75
[The status of indices of immunity and hemostasis in patients with lung cancer and their changes due to general anesthesia and surgical trauma]. Anesteziol Reanimatol (1993) 0.75
[Ultrasound guided catheterization of thoracic paravertebral space]. Anesteziol Reanimatol (2015) 0.75
[Changes in the enterochromaffin and pituitary-adrenal systems in the immediate postoperative period in children with nephroblastomas]. Anesteziol Reanimatol (1982) 0.75
[The comparative characteristics of anesthesia methods in operations for tumors located on the extremities]. Anesteziol Reanimatol (1993) 0.75
[Resection of the left lobe of the liver for primary cancer in an 11-year-old child]. Pediatriia (1976) 0.75
[Effect of levamisole on the cytotoxic activity of normal lymphocytes in tissue culture]. Biull Eksp Biol Med (1979) 0.75
[Evaluation of the adequacy of general anesthesia induced by ataralgesia in oncological operations]. Anesteziol Reanimatol (1978) 0.75
[Correlation of the trophoblastic beta 1-globulin and chorionic gonadotropin indices and the clinical course of the disease in uterine chorionepithelioma]. Akush Ginekol (Mosk) (1981) 0.75
[Immune reactions in assessing the disease prognosis in soft tissue sarcomas]. Vopr Onkol (1979) 0.75
[Problems of nephroblastoma in children]. Vopr Onkol (1982) 0.75
[Use of nitrous oxide as a component of general anesthesia monitored by pulse oximetry during one-lung ventilation]. Anesteziol Reanimatol (1994) 0.75
[Postoperative epidural bupivacaine infusion in pediatric oncology]. Anesteziol Reanimatol (2006) 0.75
[Role of immunotherapy in the combined treatment of lung cancer]. Vopr Onkol (1982) 0.75
[Effect of certain narcotic substances on the oxidative and energy-forming processes in the myocardial mitochondria of dogs]. Dokl Akad Nauk SSSR (1966) 0.75
[Pulmonary edema and bronchospasm in the surgery of multivalvular heart defects]. Zh Eksp Klin Med (1966) 0.75
[The use of moradol for optimizing the recovery from neuroleptanesthesia]. Anesteziol Reanimatol (1992) 0.75
[Lymphocyte subpopulations in malignant growths]. Vopr Onkol (1984) 0.75
[Use of neuroleptoanalgesia in angiographic studies in children]. Khirurgiia (Mosk) (1970) 0.75
[Correction of metabolic disturbances in cancer patients in the early postanesthesia period]. Khirurgiia (Mosk) (2010) 0.75
[The effect of different types of anesthesia on blood coagulating and anticoagulating systems in patients with stomach cancer]. Anesteziol Reanimatol (1983) 0.75
[Immunodiagnosis and immunotherapy of bladder tumors]. Urol Nefrol (Mosk) (1984) 0.75
[Dynamics of several hormones in the blood during oncologic surgery under neuroleptoanalgesia]. Vestn Akad Med Nauk SSSR (1976) 0.75
[Changes in the activity of nonspecific liver oxidases after surgery for cancer in children]. Pediatriia (1982) 0.75
[A case of idiosyncrasy to sevoflurane in a patient with bilateral nephroblastoma and WAGR syndrome]. Anesteziol Reanimatol (2009) 0.75
[A cytochemical study of the interrelationship between lymphocytes and target cells in tissue culture]. Biull Eksp Biol Med (1967) 0.75
[Radiotherapy of malignant tumors in children]. Vopr Onkol (1991) 0.75
[Use of fluothane anesthesia and neuroleptoanalgesia for controlled hypotonia in oncological surgery]. Eksp Khir Anesteziol (1974) 0.75
[Immunologic heterogeneity of acute lymphoblastic leukemia in children detected with xenogeneic antisera]. Ter Arkh (1983) 0.75
[Effect of general anesthesia and surgery on the neuro-endocrine system of patients with breast neoplasms]. Anesteziol Reanimatol (1978) 0.75
[Immunologic status of patients with acquired dyserythropoietic anemia]. Gematol Transfuziol (1985) 0.75
[The effect of surgical trauma on the metabolism of essential fatty acids in patients with cancer of the esophagus and stomach]. Vopr Onkol (1990) 0.75
[Ataralgesia for minor oncologic surgery]. Vestn Akad Med Nauk SSSR (1979) 0.75
[Combined spinal epidural anesthesia during endoprosthetic surgeries for bone tumors in old-age children]. Anesteziol Reanimatol (2005) 0.75
[Hormonal-metabolic shifts in patients with breast tumors during anesthesia and surgery]. Vestn Akad Med Nauk SSSR (1979) 0.75
[Tracheobronchial obstruction and general anesthesia in patients with mediastinal tumors]. Anesteziol Reanimatol (1993) 0.75
[Treatment of limb osteosarcoma at the turn of the century (half century of experience in research)]. Vestn Ross Akad Med Nauk (2001) 0.75
[Immune response in patients with lung cancer]. Vopr Onkol (1979) 0.75
[A method of modified neuroleptanalgesia in lung surgery]. Vestn Akad Med Nauk SSSR (1990) 0.75
[An evaluation of the effect of certain factors on the hemodynamics during anesthesia induction in stomach cancer patients]. Anesteziol Reanimatol (1990) 0.75
[Dynamics of immunoregulator T-lymphocytes and its importance in the chemo-immunotherapy of lymphoproliferative diseases in children]. Vopr Onkol (1982) 0.75
[Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease]. Vopr Onkol (1983) 0.75
[Changes in the function of the kidney and water-salt metabolism in patients with extensive extirpation of the uterus with its appendages under neuroleptoanesthesia]. Vestn Akad Med Nauk SSSR (1976) 0.75
[Cellular and humoral immunity in patients with benign tumors and tumor-like formations of ovaries]. Sov Med (1982) 0.75
[Aspects of the study of immunity in patients with kidney tumors]. Urol Nefrol (Mosk) (1984) 0.75
[The effect of indomethacin and leukinferon on the thromboxane B2 level in the blood plasma of patients with endometrial cancer in the perioperative period]. Vopr Onkol (1992) 0.75
[Surgical stress in pediatric oncology]. Vopr Onkol (1990) 0.75
[Effect of electroanesthesia and neuroleptanalgesia on blood plasma beta-endorphin level during surgical intervention in cancer patients]. Anesteziol Reanimatol (1989) 0.75
[Accumulation of gaseous products of lipid peroxidation in the expired air of human subjects during hyperbaric oxygenation]. Biull Eksp Biol Med (1983) 0.75
[State of cerebral circulation during operations under neuroleptoanalgesia and under conditions of fluorothane controlled hypotension in oncological patients]. Sov Zdravookhr Kirg (1973) 0.75
[Variants in the course of Sjögren's disease]. Ter Arkh (1982) 0.75
[ICO-1 monoclonal antibodies against the constant region of Ia-like (Dr) antigens]. Eksp Onkol (1984) 0.75
[Use of immunologic tests to predict the course of stomach cancer]. Vestn Akad Med Nauk SSSR (1981) 0.75
Suppressor cells in melanoma and lung cancer: correlation with the clinical stage. Neoplasma (1983) 0.75
[Clinical and physiological assessment of esmerone (rocuronium bromide) during oncologic surgeries in adolescents]. Anesteziol Reanimatol (2004) 0.75
[Clinico-biochemical parallels in neuroblastoma in children]. Pediatriia (1977) 0.75
[Use of immunological methods in the oncological clinic]. Vestn Akad Med Nauk SSSR (1982) 0.75
[Immunological reactivity study of patients with uterine trophoblastic tumors]. Vopr Onkol (1979) 0.75
[Characteristics of the anesthesiological assistance in catecholamine-producing chemodectomas]. Klin Khir (1984) 0.75